1. R. Vitolina, A. Kimenis, Effects of tetrahydropyrimidine derivatives on the cardiovascular system, Khim.-Farm. Zh. 23 (1989) 285 [Chem. Abstr. 111 (1989) 188c].
2. V.V. Kastron, R. Vitolina, E.L. Khanina, G. Duburs, A. Kimenis, N.V. Kondratenko, V.I. Popov, L.M. Yagupol’skii, A.A. Kolomeitsev, Preparation of 2-oxo-4-(2′-difluoromethyl thiophenyl)-5-methoxycarbonyl-6-methyl-1,2,3,4-tetrahydropyrimidine having coronary-dilating activity, US Patent 4,738,965 (1988) [Chem. Abstr. 110 (1989) 18547h].
3. Dihydropyrimidines: novel calcium antagonists with potent and long-lasting vasodilative and antihypertensive activity;Cho;J. Med. Chem.,1989
4. G.C. Rovynak, K.S. Atwal, A. Hedberg, S.D. Kimball, S. Moreland, J.Z. Gougoutas, B.C. O’Reilly, J. Schwartz, M.F. Malley, Dihydropyrimidine calcium channel blockers. 4. 3-Substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents, J. Med. Chem. 35 (1992) 3254 and literature cited therein.
5. Synthesis and calcium antagonistic activity of some new 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives;Ertan;Arch. Pharm. (Weinheim),1991